Healthcare -
Medical - Diagnostics & Research - NASDAQ - DE
$ 4.83
2.99 %
$ 10.7 M
Market Cap
-0.11
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
387.20%
EBIT
Estimate
--55.44%
Net Income
Estimate
0.39%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Mainz Biomed B.V.
MYNZ has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart MYNZ
EBIT FORECAST
EBIT Forecast Chart MYNZ
NET INCOME FORECAST
Net Income Chart MYNZ